Navigation Links
ViroPharma Provides Update on Vancocin(R)
Date:1/8/2008

view in the Center. The stated mission of OPS is to ensure that high quality, safe and effective, new and generic drugs are available to the public by applying sound scientific and regulatory standards. The OPS oversees the activities of several FDA offices, including the OGD.

About ViroPharma Incorporated

ViroPharma Incorporated is committed to the development of products that address serious diseases treated by physician specialists and in hospital settings. Vancocin(R) is approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/docs/Vancocin_pi_2007.htm). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the Company's website at http://www.viropharma.com.

Certain statements in this press release may contain forward-looking statements that involve a number of risks and uncertainties, including the Company's plans to continue to oppose vigorously any bioequivalence approach considered for use in approving generic formulations of Vancocin that does not require rigorous scientific methods to demonstrate safety and efficacy consistent with good medicine and science. There can be no assurance that the FDA will agree with the positions stated in ViroPharma's Vancocin related submissions or that ViroPharma's efforts to oppose the OGD's March 2006 recommendation to determine bioequivalence to Vancocin through in vitro dissolution testing will be successful. We cannot predict the timeframe in which the FDA will make a decision regarding either
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. ViroPharma Augments Senior Management
2. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
3. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
4. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
5. ViroPharma to Present at the UBS Global Life Sciences Conference
6. ViroPharma to Present at the Maxim Group First Annual Growth Conference
7. HearAtLast Holdings, Inc. Provides Shareholder Update
8. Mayo Clinic Proceedings provides forum for debate about capital punishment
9. Kaiser Permanente Provides $1.4 Million in Holiday Gifts to 40 Metro Atlanta Nonprofits
10. Akela Pharma provides corporate update
11. Genomic Health Announces Oncotype DX(R) Provides Additional Prognostic Benefit in Patients Assessed With Adjuvant Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... ... ... gains access to someone’s email account, it can lead to all sorts of trouble, both ... issued a scam alert about a social engineering scam which cons a target into ... the hacker. All they have to do is click for a password reset and ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... lineup for its 2015 Annual Conference , the premiere continuing education ... the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers include the leading ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... place on June 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel ... to injured bicyclists and practical points of investigating these types of cases. , ...
(Date:7/3/2015)... ... ... Selfie on a Stick ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... smartphone has an incredibly powerful camera built into it. And when someone is traveling ...
(Date:7/2/2015)... ... , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location in ... State. The premium frozen yogurt chain was listed as #22 on the Inc. 500 list ... Village at Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2
... 37 Others in Screening for,Life-Threatening, Genetic Disease, WASHINGTON, ... other states and the District of Columbia in,requiring that ... In addition, the Nevada Department of Health has ... will be implemented when,state lawmakers set an implementation date., ...
... 2008 High cholesterol levels are considered to be ... many cholesterol lowering drugs have been developed by pharmaceutical ... statins, has been found to reduce the incidence of ... , In a recent paper published in the ...
... no one to turn to for emotional support other than ... when suffering from cancer. However, according to new research, the ... relationship. , Previous research has shown that many Swedish ... about the disease to few other people, if any. For ...
... Ohio An oil made of natural fatty acids that ... be paired with hormones or other substances to prevent health ... suggests. , Conjugated linoleic acid (CLA), a compound naturally found ... in some studies in humans. But a recent study in ...
... Content, Social Media and More to Promote JOHNSON,S(R) Melt ... ... April 9, 2008 JOHNSON,S(R), the,skincare expert, today announced the ... to promote its award-winning Melt,Away Stress line of skin care ...
... Aida,Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) ... the Jiangsu Province, the Jiangsu,Institute of Microbiology ... new,wide-spectrum antibiotic, Wetimicin, in the People,s Republic ... of amino-glycoside family of,antibiotics and is being ...
Cached Medicine News:Health News:Three New States Join Efforts to Screen Newborns for Cystic Fibrosis 2Health News:Dietary oil may need help in avoiding any side effects of weight loss 2Health News:Dietary oil may need help in avoiding any side effects of weight loss 3Health News:JOHNSON'S(R) Launches New Online Campaign Tapping Glam Media to Reach Young Women 2Health News:JOHNSON'S(R) Launches New Online Campaign Tapping Glam Media to Reach Young Women 3Health News:JOHNSON'S(R) Launches New Online Campaign Tapping Glam Media to Reach Young Women 4Health News:JOHNSON'S(R) Launches New Online Campaign Tapping Glam Media to Reach Young Women 5Health News:Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development 2
(Date:7/2/2015)... 2, 2015 Roche,s Bloodhound technology is ... segment in hematology testing, according to Kalorama Information.  ... unveiling of its Bloodhound digital cell imaging technology ... 511 hematology analyzer – is notable as ... by current leader CellaVision, but also compete more ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has announced the ... End-User & by Region - Global Trends & Forecast to ... is projected to reach about $2.5 Million by 2020, with ... opportunities in countries such as India , ... and Brazil . In 2013, the North ...
(Date:7/2/2015)... 2, 2015   EVO Aesthetic Center and Wellness ... for non-invasive aesthetics in Lakeway, Texas ... with the Astanza Duality laser. The medical spa is ... various medical and laser procedures. Their addition of the ... clear solution to their tattoo regret. "The ...
Breaking Medicine Technology:Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2
... Pharmaceuticals, Inc.,today announced it has raised $50 million ... utilized to support the ongoing Phase 3 development,program ... with constipation (IBS-C) and chronic constipation (CC), to ... candidates, and to,expand commercial capabilities. The financing was ...
... ATLANTA, Oct. 1 Alimera Sciences, Inc., a ... and commercialization of prescription ophthalmic,pharmaceuticals, today reported the ... first human pharmacokinetic (PK) study of Iluvien(TM)., ... the treatment of,diabetic macular edema (DME). DME is ...
Cached Medicine Technology:Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3 2Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3 3Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study 2Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study 3
... T helps provide protection to the exposed airway ... extremely lightweight making it ideal for active young ... rate of heat and moisture recovery, it ensures ... HMEs and filters have ISO standard tapered ends ...
circuitGuard™ Products are available in filter or filter/HME styles., ,High quality air cushion anesthesia masks may be packaged with any circuitGuard™ product....
... 1991 Intersurgical Incorporated manufactures ... heat and moisture exchangers, ... products, hand-held nebulizers and ... accessories and connectors for ...
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
Medicine Products: